Capak v. Epps

District Court, S.D. New York·Decided August 24, 2023·No. 1:18-cv-04325·Unknown

Opinion

USDC SDNY DOCUMENT UNITED STATES DISTRICT COURT ELECTRONICALLY FILED SOUTHERN DISTRICT OF NEW YORK DOC #: nnn nnn nnn nnn nnn nnn nen X DATE FILED: 8/24/2023 RICHARD J. CAPAK, Plaintiff, 18-cv-4325 (KHP) -against- ORDER RORY DORALL SMITH, Defendant.

nooo -----------------X KATHARINE H. PARKER, United States Magistrate Judge: This action arises out of an altercation between Plaintiff Richard Capak, a celebrity photographer and videographer, and Defendant Rory Dorall Smith, who was working as security for Former Defendant Tauheed Epps a/k/a/ 2 Chainz. On November 29, 2017, Plaintiff commenced a state court action against Defendant and Epps for assault, battery, and negligence, and on May 15, 2018, Epps removed the action to federal court based on diversity jurisdiction with Defendant’s consent. (ECF No. 3.) A bench trial in this case is scheduled to commence on Tuesday, September 12, 2023. Presently before the Court is a motion in limine submitted by Defendant at ECF No. 185. Defendant’s motion seeks (i) to limit the testimony of Plaintiff’s treating physician, and (ii) prevent Plaintiff from admitting evidence related to Defendant’s vacated guilty plea under Federal Rule of Evidence 410(a).

I. Legal Standards a. Applicable Law In cases removed to federal court based on diversity of citizenship, questions of

procedural law are governed by federal law and questions of substantive law are governed by the law of the applicable state. Hernandez v. Money Source Inc., 2022 WL 2702894, at *5 (E.D.N.Y. July 12, 2022) (citations omitted). The Rules of Evidence are procedural, and the federal rules of evidence thus apply to civil cases that are removed to the federal court. Id. (citing Fed. R. Evid. 1101).

b. Standards for Motions In Limine A trial court's “inherent authority to manage the course of its trials encompasses the right to rule on motions in limine.” Highland Capital Mgmt., L.P. v. Schneider, 551 F. Supp. 2d 173, 176 (S.D.N.Y. 2008) (citation omitted). An in limine motion is intended “to aid the trial process by enabling the Court to rule in advance of trial on the relevance of certain forecasted evidence, as to issues that are definitely set for trial, without lengthy argument at, or

interruption of, the trial.” Palmieri v. Defaria, 88 F.3d 136, 141 (2d Cir. 1996) (quotation marks and citation omitted). “Because a ruling on a motion in limine is subject to change as the case unfolds, this ruling constitutes a preliminary determination in preparation for trial.” Ridge v.Davis, 2022 WL 16737299, at *1 (S.D.N.Y. Nov. 7, 2022) (quotation and citation omitted). c. Standards for Admission of Evidence “The Federal Rules of Evidence favor the admission of all relevant evidence.” In re

Methyl Tertiary Butyl Ether Prods. Liab. Litig., 643 F. Supp. 2d 446, 452 (S.D.N.Y. 2009) (citing Fed. R. Evid. 402). “Evidence is relevant if: (a) it has any tendency to make a fact more or less 2 probable than it would be without the evidence; and (b) the fact is of consequence in determining the action.” Fed. R. Evid. 401. However, “[t]he court may exclude relevant evidence if its probative value is substantially outweighed by a danger of one or more of the

following: unfair prejudice, confusing the issues, misleading the jury, undue delay, wasting time, or needlessly presenting cumulative evidence.” Fed. R. Evid. 403. “Irrelevant evidence is not admissible.” Fed. R. Evid. 402. II. Discussion a. Treating Physician Testimony

Defendant seeks to limit the testimony of Plaintiff’s treating physicians, Dr. Ranga Krishna and Dr. Charles Kaplan, to that of a fact witness and preclude any testimony regarding causation. Defendant also argues that the treating physicians should not be permitted to testify as to causation because Plaintiff was treated or suffered from some of the alleged injuries before the encounter. Plaintiff does not dispute that his treating physicians would be unable to testify as expert witnesses because he did not file disclosures pursuant to Fed. R. Civ.

P. 26(a)(2)(B) and (C). However, Plaintiff argues that under Rodriguez v. Village of Portchester, his treating physicians would be entitled to testify as to facts acquired and opinions formed during examination of the Plaintiff, including causation. 535 F.Supp.3d 202 (S.D.N.Y. 2021). Further, Plaintiff has disclosed that only Dr. Kaplan will be testifying for the Plaintiff. (ECF No. 196.) Under the Federal Rules of Evidence only expert witnesses may provide expert medical

opinions. Fed. R. Evid. 701(c). If a witness is not testifying as an expert, then opinion testimony is limited to one that is “not based on scientific, technical, or other specialized knowledge 3 within the scope of Rule 702.” Id.; see also N.K. by Bruestle-Kumra v. Abbott Lab'ys, 731 F. App'x 24, 26 (2d Cir. 2018). When a doctor’s opinion is not offered as an expert but “offered in [the doctor’s] capacity as [a patient's] treating physician, it [i]s properly limited to his personal

knowledge developed during the course of his treatment of [the patient].” In re Fosamax Prods. Liab. Litig., 509 F. App'x 69, 74 (2d Cir. 2013) (citing Fed. R. Evid. 602). A treating physician is not permitted to introduce information that another physician provided or opine on information provided by another doctor. Salazar v. United States, 2019 WL 948865, at *3 (S.D.N.Y. Feb. 11, 2019) (quoting Stern v. Shammas, 2015 WL 4530473, at *7 (E.D.N.Y. July 27,

2015)). As there is no dispute that Plaintiff did not file expert disclosures, Plaintiff’s treating physician will be limited to testifying as a fact witness. Therefore, Dr. Kaplan must limit his testimony to what is based on his personal knowledge developed during his treatment of Plaintiff. See In re Fosamax Prods. Liab. Litig., 509 F. App'x 69, 74 (2d Cir. 2013) (finding a treating physician’s opinion was properly excluded where the treating physician testified that

he did not know the patient’s treatment history with Fosamax but that it was part of a different treating physician’s treatment). Treating physicians that are not testifying as experts are not categorically barred from testifying regarding causation, but the key factor in determining whether testimony is expert or lay is whether or not the testimony is “derived from the physician’s specialized expertise.” Kaganovich v. McDonough, 547 F. Supp. 3d 248, 276 (E.D.N.Y. 2021) (citing N.K. by Burestle-

Free access — add to your briefcase to read the full text and ask questions with AI

Capak v. Epps, (S.D.N.Y. 2023).

Capak v. Epps (Capak v. Epps) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Secrest v. Merck, Sharp & Dohme Corp.
509 F. App'x 69 (Second Circuit, 2013)
United States v. Frederick
702 F. Supp. 2d 32 (E.D. New York, 2009)
Highland Capital Management, L.P. v. Schneider
551 F. Supp. 2d 173 (S.D. New York, 2008)
In Re Methyl Tertiary Butyl Ether (" Mtbe") Products
643 F. Supp. 2d 446 (S.D. New York, 2009)
Palmieri v. Defaria
88 F.3d 136 (Second Circuit, 1996)
Wills v. Amerada Hess Corp.
379 F.3d 32 (Second Circuit, 2004)